Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT393 | Cell Line | HCT-116 | Homo sapiens | GI50 | 25003.45 | nM | 16309317 | |
NPT112 | Cell Line | MOLT-4 | Homo sapiens | GI50 | 8511.38 | nM | 11809072 | |
NPT395 | Cell Line | SF-268 | Homo sapiens | GI50 | 17498.47 | nM | 21417387 | |
NPT148 | Cell Line | HCT-15 | Homo sapiens | GI50 | 16788.04 | nM | 25735399 | |
NPT374 | Cell Line | SF-539 | Homo sapiens | GI50 | 9840.11 | nM | 11473410 | |
NPT574 | Cell Line | XF498 | Homo sapiens | GI50 | = | 25118.86 | nM | 26083682 |
NPT390 | Cell Line | LOX IMVI | Homo sapiens | GI50 | = | 8128.31 | nM | 26083682 |
NPT323 | Cell Line | SW-620 | Homo sapiens | GI50 | = | 13489.63 | nM | 26083682 |
NPT395 | Cell Line | SF-268 | Homo sapiens | GI50 | = | 17378.01 | nM | 26083682 |
NPT386 | Cell Line | KM12 | Homo sapiens | GI50 | = | 10232.93 | nM | 12932146 |
NPT575 | Cell Line | KM-20L2 | Homo sapiens | GI50 | = | 15488.17 | nM | 12141856 |
NPT392 | Cell Line | SNB-75 | Homo sapiens | GI50 | = | 22908.68 | nM | 18336005 |
NPT380 | Cell Line | U-251 | Homo sapiens | GI50 | = | 25118.86 | nM | 18336005 |
NPT374 | Cell Line | SF-539 | Homo sapiens | GI50 | = | 9772.37 | nM | 18336005 |
NPT383 | Cell Line | SNB-19 | Homo sapiens | GI50 | = | 25118.86 | nM | 18336005 |
NPT111 | Cell Line | K562 | Homo sapiens | GI50 | 9705.1 | nM | 17190444 | |
NPT146 | Cell Line | SK-OV-3 | Homo sapiens | GI50 | 25003.45 | nM | 15974627 | |
NPT372 | Cell Line | HOP-92 | Homo sapiens | GI50 | 5395.11 | nM | 21215622 | |
NPT385 | Cell Line | SR | Homo sapiens | GI50 | 16634.13 | nM | 22946634 | |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | 10839.27 | nM | Open TG-GATES in vivo data: Pathology | |
NPT373 | Cell Line | SK-MEL-5 | Homo sapiens | GI50 | 25003.45 | nM | 26331426 | |
NPT573 | Cell Line | M19-MEL | Homo sapiens | GI50 | 25003.45 | nM | PubChem BioAssay data set | |
NPT116 | Cell Line | HL-60 | Homo sapiens | GI50 | 12274.39 | nM | PubChem BioAssay data set | |
NPT391 | Cell Line | HCC 2998 | Homo sapiens | GI50 | 25003.45 | nM | PubChem BioAssay data set | |
NPT388 | Cell Line | NCI-H322M | Homo sapiens | GI50 | = | 25118.86 | nM | 25314007 |
NPT397 | Cell Line | NCI-H460 | Homo sapiens | GI50 | = | 10715.19 | nM | 25314007 |
NPT81 | Cell Line | A549 | Homo sapiens | GI50 | = | 23442.29 | nM | 25314007 |
NPT379 | Cell Line | HOP-62 | Homo sapiens | GI50 | = | 6606.93 | nM | 25314007 |
NPT372 | Cell Line | HOP-92 | Homo sapiens | GI50 | = | 5370.32 | nM | 25314007 |
NPT405 | Cell Line | NCI-H226 | Homo sapiens | GI50 | = | 16982.44 | nM | 25314007 |
NPT111 | Cell Line | K562 | Homo sapiens | GI50 | = | 9772.37 | nM | 25314007 |
NPT112 | Cell Line | MOLT-4 | Homo sapiens | GI50 | = | 8511.38 | nM | 26848627 |
NPT2 | Others | Unspecified | GI50 | = | 25118.86 | nM | 26848627 | |
NPT385 | Cell Line | SR | Homo sapiens | GI50 | = | 16595.87 | nM | 26848627 |
NPT572 | Cell Line | DMS-273 | Homo sapiens | GI50 | 15135.61 | nM | 18442289 | |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | GI50 | = | 12022.64 | nM | DrugMatrix in vitro pharmacology data |
NPT405 | Cell Line | NCI-H226 | Homo sapiens | GI50 | 16982.44 | nM | PubChem BioAssay data set | |
NPT458 | Cell Line | IGROV-1 | Homo sapiens | GI50 | 25003.45 | nM | 25316316 | |
NPT139 | Cell Line | HT-29 | Homo sapiens | GI50 | = | 16982.44 | nM | 15497941 |
NPT148 | Cell Line | HCT-15 | Homo sapiens | GI50 | = | 16982.44 | nM | 18078747 |
NPT579 | Cell Line | DLD-1 | Homo sapiens | GI50 | = | 25118.86 | nM | 18095654 |
NPT407 | Cell Line | COLO 205 | Homo sapiens | GI50 | = | 25118.86 | nM | 16854055 |
NPT393 | Cell Line | HCT-116 | Homo sapiens | GI50 | = | 25118.86 | nM | 18851910 |
NPT391 | Cell Line | HCC 2998 | Homo sapiens | GI50 | = | 25118.86 | nM | 18851910 |
NPT2 | Others | Unspecified | GI50 | = | 16982.44 | nM | 18851910 | |
NPT455 | Cell Line | NCI-H522 | Homo sapiens | GI50 | = | 5370.32 | nM | 8904842 |
NPT572 | Cell Line | DMS-273 | Homo sapiens | GI50 | = | 15135.61 | nM | 8904842 |
NPT2 | Others | Unspecified | GI50 | = | 19952.62 | nM | 8904842 | |
NPT380 | Cell Line | U-251 | Homo sapiens | GI50 | 25003.45 | nM | 14695800 | |
NPT368 | Cell Line | SN12C | Homo sapiens | GI50 | 25003.45 | nM | 9917283 | |
NPT407 | Cell Line | COLO 205 | Homo sapiens | GI50 | 25003.45 | nM | 21625478 | |
NPT404 | Cell Line | CCRF-CEM | Homo sapiens | GI50 | 11994.99 | nM | 20553004 | |
NPT2 | Others | Unspecified | GI50 | = | 12302.69 | nM | 22372931 | |
NPT575 | Cell Line | KM-20L2 | Homo sapiens | GI50 | 15417 | nM | 18650090 | |
NPT574 | Cell Line | XF498 | Homo sapiens | GI50 | 25003.45 | nM | 18443128 | |
NPT401 | Cell Line | 786-0 | Homo sapiens | GI50 | 25003.45 | nM | 19738026 | |
NPT381 | Cell Line | OVCAR-8 | Homo sapiens | GI50 | 10495.42 | nM | 20696876 | |
NPT323 | Cell Line | SW-620 | Homo sapiens | GI50 | 13427.65 | nM | DrugMatrix in vitro pharmacology data | |
NPT2 | Others | Unspecified | GI50 | = | 10471.29 | nM | 10.1007/s00044-011-9876-x | |
NPT146 | Cell Line | SK-OV-3 | Homo sapiens | GI50 | = | 25118.86 | nM | 10.1007/s00044-011-9876-x |
NPT401 | Cell Line | 786-0 | Homo sapiens | GI50 | = | 25118.86 | nM | 10.1007/s00044-011-9876-x |
NPT369 | Cell Line | ACHN | Homo sapiens | GI50 | = | 12302.69 | nM | 10.1007/s00044-011-9876-x |
NPT368 | Cell Line | SN12C | Homo sapiens | GI50 | = | 25118.86 | nM | 10.1007/s00044-011-9876-x |
NPT384 | Cell Line | TK-10 | Homo sapiens | GI50 | = | 25118.86 | nM | 10.1007/s00044-011-9876-x |
NPT371 | Cell Line | UO-31 | Homo sapiens | GI50 | = | 25118.86 | nM | 10.1007/s00044-011-9808-9 |
NPT389 | Cell Line | RPMI-8226 | Homo sapiens | GI50 | 25003.45 | nM | 26035018 | |
NPT578 | Cell Line | SNB-78 | Homo sapiens | GI50 | 23120.65 | nM | PubChem BioAssay data set | |
NPT81 | Cell Line | A549 | Homo sapiens | GI50 | 23173.95 | nM | 16933872 | |
NPT386 | Cell Line | KM12 | Homo sapiens | GI50 | 10232.93 | nM | 14640511 | |
NPT170 | Cell Line | SK-MEL-28 | Homo sapiens | GI50 | 25003.45 | nM | 17844994 | |
NPT388 | Cell Line | NCI-H322M | Homo sapiens | GI50 | 25003.45 | nM | PubChem BioAssay data set | |
NPT147 | Cell Line | SK-MEL-2 | Homo sapiens | GI50 | 25003.45 | nM | 17894480 | |
NPT576 | Cell Line | DMS-114 | Homo sapiens | GI50 | 19998.62 | nM | Open TG-GATES in vivo data: Hematology | |
NPT377 | Cell Line | OVCAR-3 | Homo sapiens | GI50 | 10209.39 | nM | Open TG-GATES in vivo data: Biochemistry | |
NPT383 | Cell Line | SNB-19 | Homo sapiens | GI50 | 25003.45 | nM | Open TG-GATES in vivo data: Biochemistry | |
NPT387 | Cell Line | M14 | Homo sapiens | GI50 | 6266.14 | nM | Open TG-GATES in vivo data: Organ Weight | |
NPT375 | Cell Line | Malme-3M | Homo sapiens | GI50 | 25003.45 | nM | Open TG-GATES in vivo data: Organ Weight | |
NPT369 | Cell Line | ACHN | Homo sapiens | GI50 | 12189.9 | nM | 19754130 | |
NPT379 | Cell Line | HOP-62 | Homo sapiens | GI50 | 6622.17 | nM | 17190456 | |
NPT147 | Cell Line | SK-MEL-2 | Homo sapiens | GI50 | = | 25118.86 | nM | 15043424 |
NPT573 | Cell Line | M19-MEL | Homo sapiens | GI50 | = | 25118.86 | nM | 15043424 |
NPT387 | Cell Line | M14 | Homo sapiens | GI50 | = | 6309.57 | nM | 15387640 |
NPT375 | Cell Line | Malme-3M | Homo sapiens | GI50 | = | 25118.86 | nM | 9157192 |
NPT458 | Cell Line | IGROV-1 | Homo sapiens | GI50 | = | 25118.86 | nM | 9157192 |
NPT398 | Cell Line | UACC-62 | Homo sapiens | GI50 | = | 15135.61 | nM | 9157192 |
NPT373 | Cell Line | SK-MEL-5 | Homo sapiens | GI50 | = | 25118.86 | nM | 9917283 |
NPT170 | Cell Line | SK-MEL-28 | Homo sapiens | GI50 | = | 25118.86 | nM | 9917283 |
NPT2 | Others | Unspecified | GI50 | = | 25118.86 | nM | 9917283 | |
NPT2 | Others | Unspecified | GI50 | = | 10232.93 | nM | 9917283 | |
NPT384 | Cell Line | TK-10 | Homo sapiens | GI50 | 25003.45 | nM | 24926807 | |
NPT455 | Cell Line | NCI-H522 | Homo sapiens | GI50 | 5432.5 | nM | 26200396 | |
NPT382 | Cell Line | OVCAR-5 | Homo sapiens | GI50 | 25003.45 | nM | 17261619 | |
NPT139 | Cell Line | HT-29 | Homo sapiens | GI50 | 16943.38 | nM | PubChem BioAssay data set | |
NPT731 | Cell Line | LXFL 529 | Homo sapiens | GI50 | 16943.38 | nM | 10.6019/CHEMBL1201861 | |
NPT398 | Cell Line | UACC-62 | Homo sapiens | GI50 | 14996.85 | nM | 10.6019/CHEMBL1201861 | |
NPT390 | Cell Line | LOX IMVI | Homo sapiens | GI50 | 8184.65 | nM | 20392109 | |
NPT371 | Cell Line | UO-31 | Homo sapiens | GI50 | 25003.45 | nM | 3404153 | |
NPT579 | Cell Line | DLD-1 | Homo sapiens | GI50 | 25003.45 | nM | 19349520 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC94157 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9641 | High Similarity | NPC132642 |
0.9353 | High Similarity | NPC473185 |
0.9278 | High Similarity | NPC199667 |
0.9227 | High Similarity | NPC473181 |
0.9216 | High Similarity | NPC475253 |
0.9184 | High Similarity | NPC473180 |
0.9082 | High Similarity | NPC39370 |
0.9078 | High Similarity | NPC473186 |
0.9005 | High Similarity | NPC473179 |
0.8995 | High Similarity | NPC473183 |
0.89 | High Similarity | NPC473184 |
0.8883 | High Similarity | NPC242928 |
0.868 | High Similarity | NPC475774 |
0.8667 | High Similarity | NPC128823 |
0.8564 | High Similarity | NPC474798 |
0.8502 | High Similarity | NPC477533 |
0.8498 | Intermediate Similarity | NPC473182 |
0.8451 | Intermediate Similarity | NPC469554 |
0.8382 | Intermediate Similarity | NPC208284 |
0.8364 | Intermediate Similarity | NPC101543 |
0.8358 | Intermediate Similarity | NPC470930 |
0.831 | Intermediate Similarity | NPC314954 |
0.8308 | Intermediate Similarity | NPC476138 |
0.8308 | Intermediate Similarity | NPC245816 |
0.8302 | Intermediate Similarity | NPC202503 |
0.825 | Intermediate Similarity | NPC329793 |
0.8238 | Intermediate Similarity | NPC473189 |
0.8229 | Intermediate Similarity | NPC176127 |
0.8223 | Intermediate Similarity | NPC475190 |
0.8182 | Intermediate Similarity | NPC131017 |
0.8164 | Intermediate Similarity | NPC26679 |
0.8157 | Intermediate Similarity | NPC180504 |
0.8134 | Intermediate Similarity | NPC170114 |
0.8131 | Intermediate Similarity | NPC227908 |
0.8128 | Intermediate Similarity | NPC162484 |
0.8125 | Intermediate Similarity | NPC39500 |
0.8122 | Intermediate Similarity | NPC92111 |
0.8116 | Intermediate Similarity | NPC187501 |
0.8113 | Intermediate Similarity | NPC477532 |
0.8107 | Intermediate Similarity | NPC185782 |
0.8088 | Intermediate Similarity | NPC285558 |
0.8086 | Intermediate Similarity | NPC470549 |
0.8071 | Intermediate Similarity | NPC76748 |
0.8069 | Intermediate Similarity | NPC329747 |
0.8068 | Intermediate Similarity | NPC471304 |
0.806 | Intermediate Similarity | NPC72211 |
0.8056 | Intermediate Similarity | NPC252251 |
0.804 | Intermediate Similarity | NPC307963 |
0.8039 | Intermediate Similarity | NPC223427 |
0.802 | Intermediate Similarity | NPC296527 |
0.8019 | Intermediate Similarity | NPC209769 |
0.801 | Intermediate Similarity | NPC70956 |
0.801 | Intermediate Similarity | NPC243834 |
0.7991 | Intermediate Similarity | NPC144452 |
0.7982 | Intermediate Similarity | NPC477531 |
0.7981 | Intermediate Similarity | NPC225279 |
0.798 | Intermediate Similarity | NPC19872 |
0.798 | Intermediate Similarity | NPC176538 |
0.7972 | Intermediate Similarity | NPC184408 |
0.796 | Intermediate Similarity | NPC70259 |
0.7952 | Intermediate Similarity | NPC478074 |
0.7952 | Intermediate Similarity | NPC476287 |
0.7952 | Intermediate Similarity | NPC469592 |
0.7952 | Intermediate Similarity | NPC471080 |
0.7941 | Intermediate Similarity | NPC267423 |
0.7936 | Intermediate Similarity | NPC209174 |
0.7934 | Intermediate Similarity | NPC208084 |
0.7933 | Intermediate Similarity | NPC201697 |
0.793 | Intermediate Similarity | NPC26543 |
0.7923 | Intermediate Similarity | NPC193777 |
0.791 | Intermediate Similarity | NPC43787 |
0.791 | Intermediate Similarity | NPC205934 |
0.7908 | Intermediate Similarity | NPC84478 |
0.7897 | Intermediate Similarity | NPC86078 |
0.7877 | Intermediate Similarity | NPC8022 |
0.7877 | Intermediate Similarity | NPC470799 |
0.7876 | Intermediate Similarity | NPC56618 |
0.7871 | Intermediate Similarity | NPC251090 |
0.7861 | Intermediate Similarity | NPC473178 |
0.7818 | Intermediate Similarity | NPC474688 |
0.7816 | Intermediate Similarity | NPC475112 |
0.7816 | Intermediate Similarity | NPC291535 |
0.7816 | Intermediate Similarity | NPC475085 |
0.781 | Intermediate Similarity | NPC167860 |
0.781 | Intermediate Similarity | NPC123976 |
0.7808 | Intermediate Similarity | NPC274640 |
0.7804 | Intermediate Similarity | NPC96321 |
0.7804 | Intermediate Similarity | NPC469594 |
0.7799 | Intermediate Similarity | NPC475910 |
0.7795 | Intermediate Similarity | NPC88363 |
0.7788 | Intermediate Similarity | NPC300156 |
0.7788 | Intermediate Similarity | NPC45190 |
0.7778 | Intermediate Similarity | NPC477066 |
0.7767 | Intermediate Similarity | NPC476044 |
0.7756 | Intermediate Similarity | NPC18487 |
0.7743 | Intermediate Similarity | NPC478081 |
0.7739 | Intermediate Similarity | NPC473188 |
0.7737 | Intermediate Similarity | NPC118511 |
0.7736 | Intermediate Similarity | NPC48353 |
0.7703 | Intermediate Similarity | NPC476106 |
0.77 | Intermediate Similarity | NPC266931 |
0.7689 | Intermediate Similarity | NPC11408 |
0.7685 | Intermediate Similarity | NPC292958 |
0.7685 | Intermediate Similarity | NPC213530 |
0.7685 | Intermediate Similarity | NPC193267 |
0.7682 | Intermediate Similarity | NPC53534 |
0.7681 | Intermediate Similarity | NPC232727 |
0.7679 | Intermediate Similarity | NPC473187 |
0.7678 | Intermediate Similarity | NPC469589 |
0.7671 | Intermediate Similarity | NPC179287 |
0.7668 | Intermediate Similarity | NPC329631 |
0.7665 | Intermediate Similarity | NPC477067 |
0.7665 | Intermediate Similarity | NPC478082 |
0.7664 | Intermediate Similarity | NPC118228 |
0.7662 | Intermediate Similarity | NPC246700 |
0.7661 | Intermediate Similarity | NPC280272 |
0.7642 | Intermediate Similarity | NPC5145 |
0.7639 | Intermediate Similarity | NPC303658 |
0.763 | Intermediate Similarity | NPC477111 |
0.7623 | Intermediate Similarity | NPC49547 |
0.7621 | Intermediate Similarity | NPC217554 |
0.7619 | Intermediate Similarity | NPC472111 |
0.761 | Intermediate Similarity | NPC13880 |
0.7609 | Intermediate Similarity | NPC471891 |
0.7593 | Intermediate Similarity | NPC305984 |
0.7588 | Intermediate Similarity | NPC473540 |
0.7585 | Intermediate Similarity | NPC476167 |
0.7578 | Intermediate Similarity | NPC476451 |
0.7573 | Intermediate Similarity | NPC267928 |
0.7571 | Intermediate Similarity | NPC475070 |
0.7565 | Intermediate Similarity | NPC475666 |
0.7563 | Intermediate Similarity | NPC152620 |
0.756 | Intermediate Similarity | NPC199277 |
0.756 | Intermediate Similarity | NPC135887 |
0.7559 | Intermediate Similarity | NPC11464 |
0.7558 | Intermediate Similarity | NPC473041 |
0.7557 | Intermediate Similarity | NPC470018 |
0.7556 | Intermediate Similarity | NPC277351 |
0.7549 | Intermediate Similarity | NPC99666 |
0.7548 | Intermediate Similarity | NPC11017 |
0.7548 | Intermediate Similarity | NPC249040 |
0.7547 | Intermediate Similarity | NPC476465 |
0.7545 | Intermediate Similarity | NPC51388 |
0.7544 | Intermediate Similarity | NPC475844 |
0.7536 | Intermediate Similarity | NPC192315 |
0.7534 | Intermediate Similarity | NPC280799 |
0.7532 | Intermediate Similarity | NPC17437 |
0.7525 | Intermediate Similarity | NPC473177 |
0.7523 | Intermediate Similarity | NPC74575 |
0.7523 | Intermediate Similarity | NPC257851 |
0.7522 | Intermediate Similarity | NPC81939 |
0.7522 | Intermediate Similarity | NPC208522 |
0.7522 | Intermediate Similarity | NPC295228 |
0.7522 | Intermediate Similarity | NPC284141 |
0.7512 | Intermediate Similarity | NPC94943 |
0.7512 | Intermediate Similarity | NPC84853 |
0.7512 | Intermediate Similarity | NPC476041 |
0.7512 | Intermediate Similarity | NPC304926 |
0.7512 | Intermediate Similarity | NPC476116 |
0.75 | Intermediate Similarity | NPC4687 |
0.75 | Intermediate Similarity | NPC249583 |
0.7489 | Intermediate Similarity | NPC15801 |
0.7489 | Intermediate Similarity | NPC472099 |
0.7488 | Intermediate Similarity | NPC472098 |
0.7488 | Intermediate Similarity | NPC153042 |
0.7488 | Intermediate Similarity | NPC128751 |
0.7488 | Intermediate Similarity | NPC294620 |
0.7487 | Intermediate Similarity | NPC478032 |
0.7478 | Intermediate Similarity | NPC24802 |
0.7475 | Intermediate Similarity | NPC171171 |
0.7465 | Intermediate Similarity | NPC470931 |
0.7465 | Intermediate Similarity | NPC287208 |
0.7465 | Intermediate Similarity | NPC82548 |
0.7465 | Intermediate Similarity | NPC477110 |
0.7463 | Intermediate Similarity | NPC190007 |
0.7455 | Intermediate Similarity | NPC310118 |
0.7454 | Intermediate Similarity | NPC271215 |
0.7454 | Intermediate Similarity | NPC149471 |
0.7453 | Intermediate Similarity | NPC477113 |
0.7451 | Intermediate Similarity | NPC469497 |
0.7451 | Intermediate Similarity | NPC106833 |
0.7444 | Intermediate Similarity | NPC478078 |
0.7444 | Intermediate Similarity | NPC157931 |
0.7442 | Intermediate Similarity | NPC294375 |
0.7426 | Intermediate Similarity | NPC314002 |
0.7426 | Intermediate Similarity | NPC42591 |
0.7424 | Intermediate Similarity | NPC477861 |
0.7418 | Intermediate Similarity | NPC283117 |
0.7416 | Intermediate Similarity | NPC476582 |
0.7416 | Intermediate Similarity | NPC4071 |
0.7416 | Intermediate Similarity | NPC476578 |
0.7415 | Intermediate Similarity | NPC478080 |
0.7413 | Intermediate Similarity | NPC212535 |
0.7411 | Intermediate Similarity | NPC253580 |
0.7411 | Intermediate Similarity | NPC311906 |
0.7407 | Intermediate Similarity | NPC316981 |
0.7404 | Intermediate Similarity | NPC77555 |
0.7399 | Intermediate Similarity | NPC103687 |
0.7399 | Intermediate Similarity | NPC132631 |
0.7397 | Intermediate Similarity | NPC46561 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC94157 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.8384 | Intermediate Similarity | NPD4118 | Clinical (unspecified phase) |
0.8186 | Intermediate Similarity | NPD7222 | Phase 2 |
0.816 | Intermediate Similarity | NPD6160 | Clinical (unspecified phase) |
0.8098 | Intermediate Similarity | NPD7452 | Approved |
0.8098 | Intermediate Similarity | NPD7453 | Approved |
0.8058 | Intermediate Similarity | NPD5658 | Approved |
0.804 | Intermediate Similarity | NPD1038 | Approved |
0.804 | Intermediate Similarity | NPD1304 | Clinical (unspecified phase) |
0.8 | Intermediate Similarity | NPD3324 | Clinical (unspecified phase) |
0.7981 | Intermediate Similarity | NPD7678 | Clinical (unspecified phase) |
0.794 | Intermediate Similarity | NPD5913 | Phase 3 |
0.794 | Intermediate Similarity | NPD5912 | Clinical (unspecified phase) |
0.7915 | Intermediate Similarity | NPD5903 | Approved |
0.7915 | Intermediate Similarity | NPD5902 | Approved |
0.7874 | Intermediate Similarity | NPD3003 | Approved |
0.7822 | Intermediate Similarity | NPD4418 | Discontinued |
0.7788 | Intermediate Similarity | NPD8403 | Phase 1 |
0.7778 | Intermediate Similarity | NPD6344 | Clinical (unspecified phase) |
0.7773 | Intermediate Similarity | NPD4502 | Phase 2 |
0.7756 | Intermediate Similarity | NPD3825 | Phase 3 |
0.7727 | Intermediate Similarity | NPD5559 | Phase 2 |
0.7721 | Intermediate Similarity | NPD6985 | Discontinued |
0.771 | Intermediate Similarity | NPD5612 | Discontinued |
0.7685 | Intermediate Similarity | NPD7194 | Discontinued |
0.7685 | Intermediate Similarity | NPD3402 | Phase 1 |
0.7685 | Intermediate Similarity | NPD3875 | Discontinued |
0.7668 | Intermediate Similarity | NPD6741 | Clinical (unspecified phase) |
0.7662 | Intermediate Similarity | NPD6503 | Clinical (unspecified phase) |
0.765 | Intermediate Similarity | NPD6242 | Discontinued |
0.765 | Intermediate Similarity | NPD5256 | Discontinued |
0.7619 | Intermediate Similarity | NPD5530 | Phase 1 |
0.7598 | Intermediate Similarity | NPD5575 | Clinical (unspecified phase) |
0.7585 | Intermediate Similarity | NPD8396 | Approved |
0.7585 | Intermediate Similarity | NPD1768 | Approved |
0.7585 | Intermediate Similarity | NPD8395 | Approved |
0.7547 | Intermediate Similarity | NPD2189 | Approved |
0.7547 | Intermediate Similarity | NPD2187 | Approved |
0.7545 | Intermediate Similarity | NPD4885 | Approved |
0.7532 | Intermediate Similarity | NPD8358 | Approved |
0.7512 | Intermediate Similarity | NPD7823 | Clinical (unspecified phase) |
0.7511 | Intermediate Similarity | NPD7558 | Phase 2 |
0.7488 | Intermediate Similarity | NPD7948 | Phase 1 |
0.7477 | Intermediate Similarity | NPD4429 | Discontinued |
0.7476 | Intermediate Similarity | NPD6861 | Clinical (unspecified phase) |
0.7463 | Intermediate Similarity | NPD5083 | Clinical (unspecified phase) |
0.7455 | Intermediate Similarity | NPD5479 | Discontinued |
0.7446 | Intermediate Similarity | NPD5483 | Clinical (unspecified phase) |
0.7445 | Intermediate Similarity | NPD3006 | Discontinued |
0.7442 | Intermediate Similarity | NPD5066 | Phase 2 |
0.7442 | Intermediate Similarity | NPD5067 | Phase 2 |
0.7442 | Intermediate Similarity | NPD5936 | Approved |
0.7442 | Intermediate Similarity | NPD5939 | Approved |
0.7429 | Intermediate Similarity | NPD4511 | Phase 1 |
0.7419 | Intermediate Similarity | NPD6140 | Clinical (unspecified phase) |
0.7418 | Intermediate Similarity | NPD1392 | Approved |
0.7411 | Intermediate Similarity | NPD7555 | Discontinued |
0.7406 | Intermediate Similarity | NPD4795 | Phase 2 |
0.7404 | Intermediate Similarity | NPD7659 | Discontinued |
0.7398 | Intermediate Similarity | NPD1326 | Approved |
0.7398 | Intermediate Similarity | NPD1325 | Approved |
0.7397 | Intermediate Similarity | NPD5632 | Approved |
0.7387 | Intermediate Similarity | NPD6159 | Phase 2 |
0.7364 | Intermediate Similarity | NPD3763 | Approved |
0.7364 | Intermediate Similarity | NPD3514 | Clinical (unspecified phase) |
0.7356 | Intermediate Similarity | NPD3478 | Clinical (unspecified phase) |
0.7356 | Intermediate Similarity | NPD3477 | Phase 2 |
0.7352 | Intermediate Similarity | NPD5164 | Discontinued |
0.735 | Intermediate Similarity | NPD3920 | Phase 2 |
0.7349 | Intermediate Similarity | NPD2125 | Clinical (unspecified phase) |
0.734 | Intermediate Similarity | NPD6610 | Clinical (unspecified phase) |
0.7333 | Intermediate Similarity | NPD2175 | Phase 3 |
0.7333 | Intermediate Similarity | NPD5999 | Phase 2 |
0.7333 | Intermediate Similarity | NPD2176 | Approved |
0.7333 | Intermediate Similarity | NPD2177 | Approved |
0.7333 | Intermediate Similarity | NPD7710 | Clinical (unspecified phase) |
0.7321 | Intermediate Similarity | NPD6769 | Clinical (unspecified phase) |
0.7318 | Intermediate Similarity | NPD8109 | Clinical (unspecified phase) |
0.7311 | Intermediate Similarity | NPD5669 | Clinical (unspecified phase) |
0.7311 | Intermediate Similarity | NPD6961 | Discontinued |
0.7302 | Intermediate Similarity | NPD7672 | Approved |
0.7302 | Intermediate Similarity | NPD7671 | Approved |
0.7296 | Intermediate Similarity | NPD5044 | Phase 2 |
0.7295 | Intermediate Similarity | NPD3923 | Approved |
0.7295 | Intermediate Similarity | NPD3924 | Approved |
0.7295 | Intermediate Similarity | NPD3922 | Approved |
0.7295 | Intermediate Similarity | NPD3921 | Approved |
0.7295 | Intermediate Similarity | NPD8363 | Approved |
0.7295 | Intermediate Similarity | NPD8364 | Approved |
0.7294 | Intermediate Similarity | NPD1322 | Clinical (unspecified phase) |
0.7293 | Intermediate Similarity | NPD4454 | Phase 2 |
0.7289 | Intermediate Similarity | NPD7994 | Phase 2 |
0.7284 | Intermediate Similarity | NPD6773 | Clinical (unspecified phase) |
0.7281 | Intermediate Similarity | NPD6220 | Phase 3 |
0.7281 | Intermediate Similarity | NPD6494 | Phase 2 |
0.7277 | Intermediate Similarity | NPD4204 | Approved |
0.7277 | Intermediate Similarity | NPD4203 | Approved |
0.7277 | Intermediate Similarity | NPD6976 | Clinical (unspecified phase) |
0.7273 | Intermediate Similarity | NPD6449 | Clinical (unspecified phase) |
0.7265 | Intermediate Similarity | NPD7219 | Approved |
0.7265 | Intermediate Similarity | NPD7221 | Approved |
0.7256 | Intermediate Similarity | NPD5429 | Discontinued |
0.7256 | Intermediate Similarity | NPD6290 | Phase 2 |
0.7253 | Intermediate Similarity | NPD7068 | Approved |
0.7253 | Intermediate Similarity | NPD7067 | Approved |
0.7251 | Intermediate Similarity | NPD4548 | Discontinued |
0.7248 | Intermediate Similarity | NPD3815 | Phase 1 |
0.7248 | Intermediate Similarity | NPD3330 | Phase 1 |
0.7248 | Intermediate Similarity | NPD3816 | Phase 1 |
0.7244 | Intermediate Similarity | NPD7603 | Discontinued |
0.7243 | Intermediate Similarity | NPD32 | Approved |
0.7243 | Intermediate Similarity | NPD31 | Approved |
0.7243 | Intermediate Similarity | NPD4034 | Approved |
0.7243 | Intermediate Similarity | NPD4035 | Approved |
0.7243 | Intermediate Similarity | NPD4037 | Approved |
0.7243 | Intermediate Similarity | NPD4036 | Approved |
0.7243 | Intermediate Similarity | NPD4039 | Approved |
0.7243 | Intermediate Similarity | NPD4038 | Approved |
0.7243 | Intermediate Similarity | NPD4033 | Approved |
0.7243 | Intermediate Similarity | NPD4122 | Approved |
0.7238 | Intermediate Similarity | NPD5003 | Discontinued |
0.7236 | Intermediate Similarity | NPD8365 | Clinical (unspecified phase) |
0.7228 | Intermediate Similarity | NPD8464 | Clinical (unspecified phase) |
0.7227 | Intermediate Similarity | NPD6643 | Discontinued |
0.7225 | Intermediate Similarity | NPD6969 | Phase 2 |
0.7225 | Intermediate Similarity | NPD6968 | Phase 2 |
0.7217 | Intermediate Similarity | NPD1739 | Approved |
0.7217 | Intermediate Similarity | NPD1740 | Approved |
0.7212 | Intermediate Similarity | NPD6978 | Phase 2 |
0.7212 | Intermediate Similarity | NPD6569 | Phase 2 |
0.7212 | Intermediate Similarity | NPD6977 | Clinical (unspecified phase) |
0.7198 | Intermediate Similarity | NPD2921 | Clinical (unspecified phase) |
0.7196 | Intermediate Similarity | NPD6991 | Approved |
0.719 | Intermediate Similarity | NPD6550 | Discontinued |
0.7188 | Intermediate Similarity | NPD6824 | Clinical (unspecified phase) |
0.7184 | Intermediate Similarity | NPD6141 | Clinical (unspecified phase) |
0.7177 | Intermediate Similarity | NPD802 | Phase 2 |
0.7173 | Intermediate Similarity | NPD3835 | Phase 3 |
0.7173 | Intermediate Similarity | NPD6243 | Phase 3 |
0.7173 | Intermediate Similarity | NPD6244 | Phase 3 |
0.7173 | Intermediate Similarity | NPD5482 | Discontinued |
0.7173 | Intermediate Similarity | NPD3833 | Phase 3 |
0.7167 | Intermediate Similarity | NPD8244 | Phase 2 |
0.7163 | Intermediate Similarity | NPD3397 | Phase 2 |
0.7162 | Intermediate Similarity | NPD3746 | Discontinued |
0.7162 | Intermediate Similarity | NPD7395 | Discontinued |
0.7157 | Intermediate Similarity | NPD5522 | Clinical (unspecified phase) |
0.715 | Intermediate Similarity | NPD6607 | Clinical (unspecified phase) |
0.7149 | Intermediate Similarity | NPD6147 | Clinical (unspecified phase) |
0.7149 | Intermediate Similarity | NPD5022 | Discontinued |
0.7143 | Intermediate Similarity | NPD4442 | Phase 2 |
0.7143 | Intermediate Similarity | NPD6590 | Discontinued |
0.7143 | Intermediate Similarity | NPD6595 | Phase 3 |
0.7143 | Intermediate Similarity | NPD4881 | Clinical (unspecified phase) |
0.7143 | Intermediate Similarity | NPD6491 | Clinical (unspecified phase) |
0.7136 | Intermediate Similarity | NPD3945 | Discontinued |
0.7131 | Intermediate Similarity | NPD6456 | Discontinued |
0.713 | Intermediate Similarity | NPD3842 | Clinical (unspecified phase) |
0.7129 | Intermediate Similarity | NPD6203 | Clinical (unspecified phase) |
0.7124 | Intermediate Similarity | NPD4890 | Phase 2 |
0.7124 | Intermediate Similarity | NPD8016 | Phase 3 |
0.7124 | Intermediate Similarity | NPD8017 | Clinical (unspecified phase) |
0.7124 | Intermediate Similarity | NPD7719 | Discontinued |
0.7119 | Intermediate Similarity | NPD8100 | Phase 3 |
0.7108 | Intermediate Similarity | NPD7414 | Clinical (unspecified phase) |
0.7106 | Intermediate Similarity | NPD7592 | Phase 2 |
0.7104 | Intermediate Similarity | NPD5417 | Clinical (unspecified phase) |
0.7101 | Intermediate Similarity | NPD1033 | Clinical (unspecified phase) |
0.7101 | Intermediate Similarity | NPD1034 | Phase 3 |
0.71 | Intermediate Similarity | NPD5680 | Clinical (unspecified phase) |
0.7098 | Intermediate Similarity | NPD5930 | Phase 3 |
0.7093 | Intermediate Similarity | NPD7050 | Clinical (unspecified phase) |
0.7093 | Intermediate Similarity | NPD7051 | Phase 3 |
0.7092 | Intermediate Similarity | NPD112 | Approved |
0.7092 | Intermediate Similarity | NPD9705 | Discontinued |
0.7091 | Intermediate Similarity | NPD6202 | Discontinued |
0.7089 | Intermediate Similarity | NPD7868 | Clinical (unspecified phase) |
0.7087 | Intermediate Similarity | NPD7424 | Clinical (unspecified phase) |
0.7085 | Intermediate Similarity | NPD8405 | Clinical (unspecified phase) |
0.7082 | Intermediate Similarity | NPD6750 | Phase 2 |
0.7075 | Intermediate Similarity | NPD6988 | Phase 1 |
0.7074 | Intermediate Similarity | NPD7567 | Approved |
0.7074 | Intermediate Similarity | NPD5801 | Clinical (unspecified phase) |
0.7067 | Intermediate Similarity | NPD6965 | Clinical (unspecified phase) |
0.7067 | Intermediate Similarity | NPD7726 | Phase 1 |
0.7064 | Intermediate Similarity | NPD6517 | Phase 3 |
0.7062 | Intermediate Similarity | NPD6251 | Discontinued |
0.7052 | Intermediate Similarity | NPD8465 | Approved |
0.7052 | Intermediate Similarity | NPD8429 | Approved |
0.7052 | Intermediate Similarity | NPD8467 | Approved |
0.7052 | Intermediate Similarity | NPD8428 | Approved |
0.7052 | Intermediate Similarity | NPD8466 | Approved |
0.7052 | Intermediate Similarity | NPD8427 | Approved |
0.7051 | Intermediate Similarity | NPD4862 | Clinical (unspecified phase) |
0.7051 | Intermediate Similarity | NPD6150 | Discontinued |
0.7048 | Intermediate Similarity | NPD6247 | Clinical (unspecified phase) |
0.7045 | Intermediate Similarity | NPD7470 | Discontinued |
0.7045 | Intermediate Similarity | NPD5416 | Discontinued |
0.7043 | Intermediate Similarity | NPD7688 | Phase 1 |
0.704 | Intermediate Similarity | NPD3440 | Clinical (unspecified phase) |
0.7039 | Intermediate Similarity | NPD4344 | Clinical (unspecified phase) |
PubChem CID   | 375158 |
ChEMBL   | CHEMBL496078 |
ZINC   |
Molecular Weight:   | 420.18 |
ALogP:   | 0.1428 |
MLogP:   | 4.1 |
XLogP:   | 6.887 |
# Rotatable Bonds:   | 7 |
Polar Surface Area:   | 39.18 |
# H-Bond Aceptor:   | 2 |
# H-Bond Donor:   | 1 |
# Rings:   | 6 |
# Heavy Atoms:   | 32 |